← FDA DRUG APPROVALS

FDA ANDA · ANDA075823

CALCITRIOL

Sponsor: TEVA PARENTERAL

APPLICATION
ANDA075823
TYPE
ANDA
ORIGINAL APPROVAL
2003-03-31
LATEST ACTION
2009-07-16
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

CALCITRIOLDiscontinued
CALCITRIOL 0.002MG/ML · INJECTABLE · INJECTION
CALCITRIOLDiscontinued
CALCITRIOL 0.001MG/ML · INJECTABLE · INJECTION

Approval history

2009-07-16Labeling · Supplement 4AP
2003-03-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →